Testosterone Cypionate in Bodybuilding: Doses, Results and Risks
Testosterone cypionate bodybuilding: what 300 to 600 mg a week did in controlled trials, what users report from cycles, the label's abuse warnings, and the blood work.
Testosterone cypionate in bodybuilding is the base of most steroid cycles for a plain reason: it is testosterone, the hormone every other anabolic steroid is a modification of, it is cheap, and its eight-day half-life suits once- or twice-weekly injections.
What separates a cycle from TRT is dose. Replacement is 75 to 200 mg a week by the Endocrine Society regimen; user reports put a first cycle at 300 to 500 mg a week and later ones higher. The best data on what those doses do come from controlled trials that gave healthy men supraphysiological testosterone for ten to twenty weeks, and from the FDA label's section on abuse. This page uses both, and keeps user reports marked as reports.
What the Trials Measured
Supraphysiological testosterone in controlled trials (testosterone enanthate, interchangeable with cypionate in practice)
Bhasin 1996, NEJM, 43 men
600 mg/week for 10 weeks, with or without training
Fat-free mass +6.1 kg with training, +3.2 kg without; placebo with training +1.9 kg; bench press and squat gains in the same order
Bhasin 2001, 61 men, GnRH-suppressed
25, 50, 125, 300 or 600 mg/week for 20 weeks
Fat-free mass and strength rose with dose; fat mass fell at the top doses; hematocrit and HDL changed in step
Baggish 2017, 140 weightlifters
Long-term users vs non-users
Users had lower left-ventricular ejection fraction and more coronary plaque, worse with longer use
What each one settled:
- 11996: steroids work without training, and more with it
- 22001: the gains in the 300 and 600 mg groups came with the largest rises in hematocrit and the largest falls in HDL; the 600 mg group had the mood changes
- 32017: years of use were associated with reduced pump function and more coronary plaque, dose- and duration-dependent
What Users Report
Forum and log reports converge on a few patterns:
- 1First "test only" cycle: 300 to 500 mg a week for 10 to 16 weeks, injected twice a week
- 2Scale weight: up 5 to 10 kg, part of it water and glycogen
- 3Strength: up across the lifts by week four to six
- 4Common complaints: water retention, nipple sensitivity, acne, tracking the estrogen rise
- 5Mood: better in most, irritable in some, worse in the weeks after the cycle ends
- 6Testicular shrinkage and loss of fertility: reported by nearly everyone who has blood work done
Later cycles add other compounds, raise the dose or move to "blast and cruise," where the user never comes off. None of this is a protocol; it is what people say they did, and the numbers that can be checked are in the blood work below.
What the Label Says About It
The Depo-Testosterone label addresses non-medical use in two places.
The warnings state that the drug "has not been shown to be safe and effective for the enhancement of athletic performance" and should not be used for it.
The Drug Abuse and Dependence section describes abuse as use at higher than recommended doses, often combined with other anabolic steroids, and lists what has been reported:
- 1Cardiovascular: cardiac arrest, myocardial infarction, hypertrophic cardiomyopathy, congestive heart failure, stroke, transient ischemic attacks
- 2Liver: hepatotoxicity
- 3Psychiatric: major depression, mania, paranoia, psychosis, hostility, aggression, hypomania, irritability
- 4Other: convulsions, dyslipidemia, testicular atrophy, subfertility, infertility
- 5Withdrawal after supratherapeutic doses stop: depressed mood, fatigue, craving, restlessness, insomnia, decreased libido, hypogonadotropic hypogonadism, lasting weeks or months
The full list, with the replacement-dose reactions alongside, is on the side effects page.
The Blood Work That Tells the Cost
What changes at cycle doses and the thresholds clinicians use
Hematocrit
Up, dose-dependent
Above 54%: stop (Endocrine Society); clot and stroke risk
HDL cholesterol
Down, dose-dependent
Larger falls with oral 17-alpha-alkylated steroids stacked on top
Blood pressure
Up (3.9/1.5 mm Hg at replacement doses in the Xyosted study; more at higher doses by reports)
Uncontrolled hypertension is a label contraindication
Estradiol
Up with testosterone
Gynecomastia, water retention; aromatase inhibitors carry their own costs
LH, FSH, sperm
Suppressed to near zero
Recovery after stopping takes months; not guaranteed
Liver enzymes
Little change from injectable testosterone alone
Rises point to orals or other causes
A minimum that makes any of this visible:

- 1A panel before the cycle
- 2A panel at six to eight weeks
- 3A panel after
Post-Cycle and Recovery
Stopping after months of suppressed LH and FSH leaves a man temporarily hypogonadal: the label's withdrawal list is the clinical description of what users call "the crash."
Forum "post-cycle therapy" uses clomiphene or tamoxifen to restart the pituitary, sometimes with hCG. There is no labeled indication for any of it. The published recovery data come from contraceptive trials of weekly testosterone, where sperm counts took a median of several months to return and did not in every man.
Men who do not recover end up on TRT, which is the circular outcome the Endocrine Society's fertility warning is about. The approved-dose side of this drug is in the TRT guide.
Sourcing and Legality
- 1Testosterone cypionate is Schedule III in the United States: possession without a prescription is a federal offense, selling it a felony
- 2Pharmacy vials carry an NDC code, a lot number and an expiry from an FDA-registered maker; the [products page](/products) lists them
- 3Everything else, including vials sold as "pharma grade," comes with no verification of dose, sterility or contents
- 4The [reviews page](/reviews) explains why user reviews of such products cannot substitute for a lab test
Frequently Asked Questions
In the 1996 trial, 600 mg a week for 10 weeks with training added 6.1 kg of fat-free mass versus 1.9 kg for training alone. Gains rise with dose, and so do hematocrit and HDL changes.
User reports put a first cycle at 300 to 500 mg a week for 10 to 16 weeks, two to five times the replacement range. The label lists the serious reactions reported at such doses and does not support them.
Users say so because it is a single compound with known effects. The trial data show the gains and the costs rising together; blood work before, during and after is the only way to see the costs.
Natural production stays suppressed for months; the label describes withdrawal symptoms of depressed mood, fatigue and low libido. Sperm recovery took a median of several months in trials and was not universal.
Long-term high-dose users in a 2017 study had lower ejection fraction and more coronary plaque, worse with longer use. At replacement doses, TRAVERSE found no excess of heart attack or stroke.
No. It is a Schedule III controlled substance in the US; it is legal only with a prescription for a medical indication.
Cypionat.com is an independent educational resource. We are not affiliated with Pfizer, Azurity or any manufacturer, pharmacy or clinic. This content is for informational purposes only and does not constitute medical advice. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.